Kalinor-Retard P

Potassium chloride, the active ingredient in Kalinor-Retard P, is a potassium supplement presented as an oral formulation for oral use. It is used to treat hypokalemia and other potassium deficiencies in patients requiring electrolyte replenishment. Restoring normal serum potassium levels supports cellular functions, including nerve impulse transmission and muscle contraction, and helps maintain cardiac rhythm.

GNH USA supplies Kalinor-Retard P as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide and other healthcare facilities.

Kalinor-Retard P, a potassium supplement, is used to correct electrolyte imbalances related to low serum potassium.

- Hypokalemia: restores normal serum potassium levels to prevent muscle weakness and cardiac complications. - Potassium deficiency: replenishes body potassium stores to support cellular function. - Post‑operative patients: maintains electrolyte balance during recovery.

Potassium chloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset may occur. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Abdominal pain: cramping. - Metallic taste: transient taste alteration. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium. - Cardiac arrhythmia: irregular heartbeat. - Muscle weakness: severe weakness. - Respiratory depression: difficulty breathing. - Cardiac arrest: life‑threatening loss of heart function. - Anaphylaxis: rare severe allergic reaction.

When using Kalinor-Retard P, several precautions should be observed to ensure safe administration. - Renal impairment: monitor serum potassium closely. - Concomitant diuretics: assess risk of potassium shifts. - Cardiac disease: avoid rapid correction of potassium. - Gastrointestinal disorders: consider delayed absorption. - Use in elderly: start with lower doses and monitor. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Potassium chloride can interact with other medicines, affecting potassium levels or drug absorption.

Major Interactions (Avoid): - ACE inhibitors: may cause excessive potassium accumulation. - ARBs: increase risk of hyperkalemia. - Potassium‑sparing diuretics: potentiate hyperkalemia.

Moderate Interactions (Monitor Closely): - NSAIDs: can reduce renal potassium excretion. - Beta‑blockers: may mask symptoms of hyperkalemia. - Digoxin: elevated potassium can alter digoxin toxicity.